Nano-X Imaging (NNOX) Cash from Investing Activities (2021 - 2026)
Nano-X Imaging (NNOX) posted quarterly Cash from Investing Activities of $8.7 million for Q1 2026, down 22.94% year-on-year from $11.3 million in Q1 2025, and up 887.13% on a QoQ basis from -$1.1 million in Q4 2025.
Nano-X Imaging (NNOX) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Nano-X Imaging (NNOX) has reported Cash from Investing Activities for 6 consecutive years, with $8.7 million the latest figure, recorded in Q1 2026.
- Quarterly Cash from Investing Activities fell 22.94% year-over-year to $8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.8 million (up 498.63% YoY) and the FY2025 annual result came in at $29.4 million, up 246.49% from the prior year.
- Cash from Investing Activities improved to $8.7 million in Q1 2026 per NNOX's latest filing, from -$1.1 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for NNOX reached as high as $18.9 million in Q2 2025 and fell as low as -$26.2 million in Q4 2024.
- A 5-year average of $4.0 million and a median of $5.7 million in 2024 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 958.57% — and 2024, when it tumbled 1254.0%.
- Year by year, Cash from Investing Activities stood at $12.8 million in 2022, then slumped by 82.19% to $2.3 million in 2023, then tumbled by 1254.0% to -$26.2 million in 2024, then soared by 95.8% to -$1.1 million in 2025, then jumped by 887.13% to $8.7 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered $8.7 million, -$1.1 million, and $260000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.48 Bn | 176.19 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 129.11 Bn | 126.23 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.68 Bn | 67.22 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.67 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.38 Bn | 27.26 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Nano-X Imaging | 62,677.99 | -44.16 Mn | -2.59 Mn | 8.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Mn |
| Mar 31, 2026 | 8.68 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Dec 31, 2025 | -1.10 Mn |
| Sep 30, 2025 | 260,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 18.95 Mn |
| Jun 30, 2025 | 18.95 Mn |
| Mar 31, 2025 | 11.27 Mn |
| Mar 31, 2025 | 11.27 Mn |
| Dec 31, 2024 | -26.24 Mn |
| Dec 31, 2024 | -26.24 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Sep 30, 2024 | 5.74 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Mar 31, 2024 | -2.06 Mn |
| Dec 31, 2023 | 2.27 Mn |
| Dec 31, 2023 | 2.27 Mn |